Ticker: PIRS
Pieris Pharmaceuticals Inc
$2.50
(-14.09%)
Since 2019
$
Real time stock price updated as of October 19, 2020, 4:21 PM
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.
Invest in Pieris Pharmaceuticals Inc on Stash
Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.
Thanks to fractional shares
Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.
Read more
Historical stock performance
Last 1 week | 3.93% |
Last 1 month | -19.32% |
Last 12 months | -24.44% |
Last 3 years | -22.59% |
Last 5 years | 4.5% |
Last 10 years | -- |
Last 15 years | -- |
Since inception | -2.85% |
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.
Pieris Pharmaceuticals Inc stock News
This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.
CNBC
about 6 hours ago
Airline shares jump after TSA screenings topped 1 million, a 7-month high
U.S. airline stocks rose sharply on Monday after airport screenings topped 1 million in a single day.
24/7 Wall Street
about 2 hours ago
IBM Earnings Just Can't Cut It
International Business Machines Corp. (NYSE: IBM) reported third-quarter financial results after markets closed Monday.
See It Market
about 21 hours ago
These 6 Stock Market ETFs Are Cheering On The Bull Market
In spite of no passing government stimulus, mixed economic data, rising covid cases and a wild pre election season, for the first time since we can remember, our core stock market ETFs are brushing off most of the negativity.
CNBC
about 2 hours ago
IBM reports third straight quarter of revenue declines
Revenue declines have returned under new IBM CEO Arvind Krishna as he seeks to sell off part of the company's largest business segment.
Why invest on Stash?
Invest affordably.
You can buy pieces of stocks and funds with any dollar amount—and our subscription plans start at just $1 per month.
Enjoy unlimited trading.
Unlike other investing apps, Stash also doesn't charge any add-on trading commissions or electronic statement fees.1
Learn how to invest.
We'll help teach you how to invest confidently through tips, articles, and ongoing personalized guidance.
Stay diversified.
We can help guide you through building a custom balanced portfolio with our
1Stash may incur ancillary fees charged by Stash and/or its custodian that are not included in the monthly Wrap-Fee.
How to buy Pieris Pharmaceuticals Inc stock on Stash
1. Enter the amount you'd like to invest in Pieris Pharmaceuticals Inc stock, then proceed to checkout.
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Read more
2. Choose a Stash plan and set up your investment account in just a few minutes.
Stash offers three subscription plans: Stash Beginner, Stash Growth, and Stash+. Our Beginner plan starts at just $1 per month.
Read more
3. Once you’ve finished your account, your Pieris Pharmaceuticals Inc shares will be added to your new portfolio.
Once your market order of Pieris Pharmaceuticals Inc stock is complete, you'll officially be a shareholder of Pieris Pharmaceuticals Inc!
Read more
Invest in Pieris Pharmaceuticals Inc on Stash
Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.
Thanks to fractional shares
Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.
Read more
Stash resources for confident investing
How to Start Investing
Getting started in the world can be intimidating. Take a look at some of these basics we put together so you can learn how to start investing.
Investing in Fractional Shares on Stash
Good news: Learn how fractional shares can make an investment a lot more affordable.
Here’s How to Research Stocks
Consider P/E ratio, profit and loss, and news when buying stocks.
Subscribe to The Wallet!
Looking for financial guidance? Check your Wallet. Every week, your inbox will be packed with market savviness and clever money management techniques. Sign up today!
More Health Care stocks
IMUX
Immunic Inc
Immunic, Inc., formerly Vital Therapies, Inc.
PTGX
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a peptide technology platform focused on discovering and developing new chemical entities (NECs) to address significant unmet medical needs.
QTRX
Quanterix Corporation
Quanterix Corporation develops ultra-sensitive digital immunoassay platform and tools for life science research and diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to detect protein biomarkers.
ENTA
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company.
MGLN
Magellan Health Inc
Magellan Health, Inc. is engaged in the healthcare management business.
NTUS
Natus Medical Incorporated
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.
147k+ reviews on App Store and Google Play™ Store
Over 3 million Americans use Stash to invest, save, and spend.
This is not an endorsement or a statement of satisfaction.
